THE BRIEFS

The Washington Post's essential guides for D.C. decision-makers

Early BriefAnalysis

Senate Dems expect seamless leadership elections. That’s by design.

In today’s edition … Supreme Court to hear case about gender-affirming care for minors ... Musk and Ramaswamy suggest DOGE may go after time changes.

By Leigh Ann Caldwell, Patrick Svitek and Alec DentDecember 3, 2024
Health BriefAnalysis

How a Supreme Court case on vaping could affect the FDA

A ruling against the FDA could upend how the agency considers applications for new tobacco products.

By David Ovalle and McKenzie BeardDecember 2, 2024
Early BriefAnalysis

The final lame duck sprint

In today’s edition … Trump’s nominee for Israeli ambassador highlights evangelical Christian support … Dr. Oz’s past Ozempic partnership presents conflict of interest for potential Medicare head.

By Leigh Ann Caldwell, Patrick Svitek and Alec DentDecember 2, 2024
Tech BriefAnalysis

Musk admits X throttles links as ‘news influencers’ take over

Hard times for the humble hyperlink and those who depend on it.

By Will Oremus and Andrea JiménezNovember 27, 2024
Health BriefAnalysis

Your next hospital stay could involve fewer IV fluid bags. Here’s why.

Today’s newsletter: Hospitals find lasting workarounds on IV fluid shortages. Pandemic response critic named to lead NIH, and more.

By Jackie Fortiér and McKenzie BeardNovember 27, 2024
Tech BriefAnalysis

Trump’s surgeon general pick called for banning social media for teens

The Washington Post’s essential guide to tech policy news.

By Cristiano Lima-Strong and Andrea JiménezNovember 26, 2024
Health BriefAnalysis

Efforts to curb ACA enrollment fraud face real-world test

Unauthorized ACA enrollments and switches triggered over 274,000 complaints this year through August. Regulators have taken steps, but their impact is unclear.

By Julie Appleby and McKenzie BeardNovember 26, 2024
Health BriefAnalysis

Lifting the curtain on the Trump health picks

The would-be leaders of the CDC and FDA have scant infectious-disease expertise and a history of questioning vaccine policies.

By McKenzie BeardNovember 25, 2024
Health BriefAnalysis

Federal watchdog urges crackdown on Medicare Advantage home visits

HHS IG says private Medicare plans pocketed $7.5 billion last year for health conditions diagnosed but not treated.

By Fred Schulte and McKenzie BeardNovember 22, 2024
Early BriefAnalysis

A pollster’s top reasons Harris lost: Inflation, inflation, inflation

In today’s edition … Former Florida attorney general Pam Bondi replaces Gaetz as Trump’s AG pick ... Biden administration tries to distribute funds ahead of Trump’s inauguration.

By Theodoric Meyer, Leigh Ann Caldwell and Alec DentNovember 22, 2024
Tech BriefAnalysis

Meta gains steam in its push to make Apple, Google verify users’ ages

The Washington Post’s essential guide to tech policy news.

By Cristiano Lima-Strong, Cat Zakrzewski and Andrea JiménezNovember 21, 2024
Health BriefAnalysis

An up-close look at the charged debate over fluoride

Fluoride skeptics say they shouldn’t be forced to drink the substance when there are unresolved scientific questions about it.

By Fenit Nirappil and McKenzie BeardNovember 21, 2024
Early BriefAnalysis

How Democrats won in districts Trump carried

In today’s edition … Trump once lambasted Project 2025 – now he’s hiring its authors ... Musk and Ramaswamy promise spending and staffing cuts to government.

By Theodoric Meyer, Leigh Ann Caldwell and Alec DentNovember 21, 2024
Tech BriefAnalysis

Flawed AI denies benefits to low-income Americans, report warns

As Trump prepares to slash spending, a new nonprofit emerges to fight automation in government benefit programs

By Will Oremus and Andrea JiménezNovember 20, 2024
Health BriefAnalysis

Nearly all Vermonters have health insurance, but care is tough to find

Policymakers have long focused on increasing the number of people insured, thinking it would help hospital finances and patient care. It hasn’t always worked.

By Phil Galewitz and McKenzie BeardNovember 20, 2024
Early BriefAnalysis

JD Vance’s first tough task

In today’s edition … Trump picks Linda McMahon for Education Department … RFK Jr. revives fluoride debate.

By Leigh Ann Caldwell, Theodoric Meyer and Alec DentNovember 20, 2024
Tech BriefAnalysis

Trump is empowering conservatives critical of Big Tech

The Washington Post’s essential guide to tech policy news.

By Cristiano Lima-Strong and Andrea JiménezNovember 19, 2024
Health BriefAnalysis

Trump’s return means Medicaid battles might resume, too

Medicaid has emerged as one potential target for GOP leaders hunting for ways to offset the cost of tax cuts.

By Dan Diamond and McKenzie BeardNovember 19, 2024
Early BriefAnalysis

Recess appointments complicate Republican honeymoon

In today’s edition … Trump has yet to make moves to divest ahead of new term … Expected Trump housing policy could increase mortgage rates.

By Leigh Ann Caldwell, Theodoric Meyer and Alec DentNovember 19, 2024
Health BriefAnalysis

RFK Jr. vs. Big Pharma vs. Big Food

Some drugmakers are trying to game out what’s next and are reaching out to their lobbyists about the impact of Kennedy’s selection.

By Rachel Roubein and McKenzie BeardNovember 18, 2024